1
|
Wang K, Chen Y, Ferguson SD and Leach RE:
MTA1 and MTA3 regulate HIF1a expression in hypoxia-treated human
trophoblast cell line HTR8/Svneo. Med J Obstet Gynecol. 1:pii:
1017. 2013.PubMed/NCBI
|
2
|
Leslie K, Whitley GS, Herse F, Dechend R,
Ashton SV, Laing K, Thilaganathan B and Cartwright JE: Increased
apoptosis, altered oxygen signaling, and antioxidant defenses in
first-trimester pregnancies with high-resistance uterine artery
blood flow. Am J Pathol. 185:2731–2741. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Tuuli MG and Longtine MS: Nelson DM.
Review: Oxygen and trophoblast biology-a source of controversy.
Placenta. 32(Suppl 2): pp. S109–S118. 2011, View Article : Google Scholar
|
4
|
Highet AR, Khoda SM, Buckberry S, Leemaqz
S, Bianco-Miotto T, Harrington E, Ricciardelli C and Roberts CT:
Hypoxia induced HIF-1/HIF-2 activity alters trophoblast
transcriptional regulation and promotes invasion. Eur J Cell Biol.
94:589–602. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Sharma S, Norris WE and Kalkunte S: Beyond
the threshold: An etiological bridge between hypoxia and immunity
in preeclampsia. J Reprod Immunol. 85:112–116. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zou Y, Yu X, Lu J, Jiang Z, Zuo Q, Fan M,
Huang S and Sun L: Decorin-mediated inhibition of human trophoblast
cells proliferation, migration, and invasion and promotion of
apoptosis in vitro. Biomed Res Int. 2015:2016292015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Zhang D, Liu H, Zeng J, Miao X, Huang W,
Chen H, Huang Y, Li Y and Ye D: Glucocorticoid exposure in early
placentation induces preeclampsia in rats via interfering
trophoblast development. Gen Comp Endocrinol. 225:61–70. 2016.
View Article : Google Scholar
|
8
|
Heazell AE, Buttle HR, Baker PN and
Crocker IP: Altered expression of regulators of caspase activity
within trophoblast of normal pregnancies and pregnancies
complicated by preeclampsia. Reprod Sci. 15:1034–1043. 2008.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Saito S and Nakashima A: A review of the
mechanism for poor placentation in early-onset preeclampsia: The
role of autophagy in trophoblast invasion and vascular remodeling.
J Reprod Immunol. 101-102:80–88. 2014. View Article : Google Scholar
|
10
|
Kanayama N, Takahashi K, Matsuura T,
Sugimura M, Kobayashi T, Moniwa N, Tomita M and Nakayama K:
Deficiency in p57Kip2 expression induces preeclampsia-like symptoms
in mice. Mol Hum Reprod. 8:1129–1135. 2002. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kadyrov M, Schmitz C, Black S, Kaufmann P
and Huppertz B: Pre-eclampsia and maternal anaemia display reduced
apoptosis and opposite invasive phenotypes of extravillous
trophoblast. Placenta. 24:540–548. 2003. View Article : Google Scholar : PubMed/NCBI
|
12
|
Unek G, Ozmen A, Mendilcioglu I, Simsek M
and Korgun ET: The expression of cell cycle related proteins PCNA,
Ki67, p27 and p57 in normal and preeclamptic human placentas.
Tissue Cell. 46:198–205. 2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Unek G, Ozmen A, Kipmen-Korgun D and
Korgun ET: Immunolocalization of PCNA, Ki67, p27 and p57 in normal
and dexamethasone-induced intrauterine growth restriction placental
development in rat. Acta Histochem. 114:31–40. 2012. View Article : Google Scholar
|
14
|
Lee MH, Reynisdóttir I and Massagué J:
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique
domain structure and tissue distribution. Genes Dev. 9:639–649.
1995. View Article : Google Scholar : PubMed/NCBI
|
15
|
Kamura T, Hara T, Kotoshiba S, Yada M,
Ishida N, Imaki H, Hatakeyama S, Nakayama K and Nakayama KI:
Degradation of p57Kip2 mediated by SCFSkp2-dependent
ubiquitylation. Proc Natl Acad Sci USA. 100:10231–10236. 2003.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Lu Z and Hunter T: Ubiquitylation and
proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2)
CDK inhibitors. Cell Cycle. 9:2342–2352. 2010. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pateras IS, Apostolopoulou K, Niforou K,
Kotsinas A and Gorgoulis VG: p57KIP2: 'Kip'ing the cell under
control. Mol Cancer Res. 7:1902–1919. 2009. View Article : Google Scholar : PubMed/NCBI
|
18
|
Kavanagh E, Vlachos P, Emourgeon V, Rodhe
J and Joseph B: p57(KIP2) control of actin cytoskeleton dynamics is
responsible for its mitochondrial pro-apoptotic effect. Cell Death
Dis. 3:e3112012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yan Y, Frisén J, Lee MH, Massagué J and
Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in
increased apoptosis and delayed differentiation during mouse
development. Genes Dev. 11:973–983. 1997. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhang P, Wong C, Liu D, Finegold M, Harper
JW and Elledge SJ: p21(CIP1) and p57(KIP2) control muscle
differentiation at the myogenin step. Genes Dev. 13:213–224. 1999.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Samuelsson MK, Pazirandeh A and Okret S: A
pro-apoptotic effect of the CDK inhibitor p57(Kip2) on
staurosporine-induced apoptosis in HeLa cells. Biochem Biophys Res
Commun. 296:702–709. 2002. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hsu S, Yu FS, Lewis J, Singh B, Borke J,
Osaki T, Athar M and Schuster G: Induction of p57 is required for
cell survival when exposed to green tea polyphenols. Anticancer
Res. 22:4115–4120. 2002.
|
23
|
Zhang P, Liégeois NJ, Wong C, Finegold M,
Hou H, Thompson JC, Silverman A, Harper JW, DePinho RA and Elledge
SJ: Altered cell differentiation and proliferation in mice lacking
p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature.
387:151–158. 1997. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rossi MN and Antonangeli F: Cellular
response upon stress: p57 contribution to the final outcome.
Mediators Inflamm. 2015:2593252015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Takahashi K, Kobayashi T and Kanayama N:
p57(Kip2) regulates the proper development of labyrinthine and
spongiotrophoblasts. Mol Hum Reprod. 6:1019–1025. 2000. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yu Q, Qiu Y, Wang X, Tang J, Liu Y, Mei L,
Li M, Yang M, Tang L, Gao H, et al: Efficient siRNA transfer to
knockdown a placenta specific lncRNA using RGD-modified
nano-liposome: A new preeclampsia-like mouse model. Int J Pharm.
546:115–124. 2018. View Article : Google Scholar : PubMed/NCBI
|
27
|
Zhang Z, Li P, Wang Y and Yan H:
Hypoxia-induced expression of CXCR4 favors trophoblast cell
migration and invasion via the activation of HIF-1α. Int J Mol Med.
42:1508–1516. 2018.PubMed/NCBI
|
28
|
Chang TS, Kim MJ, Ryoo K, Park J, Eom SJ,
Shim J, Nakayama KI, Nakayama K, Tomita M, Takahashi K, et al:
p57KIP2 modulates stress-activated signaling by inhibiting c-Jun
NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem.
278:48092–48098. 2003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Choudhary GS, Al-Harbi S and Almasan A:
Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 1219:1–9. 2015.
View Article : Google Scholar
|
30
|
Yang Y, Zhang J, Gong Y, Liu X, Bai Y, Xu
W and Zhou R: Increased expression of prostasin contributes to
early-onset severe preeclampsia through inhibiting trophoblast
invasion. J Perinatol. 35:16–22. 2015. View Article : Google Scholar
|
31
|
Ma J, Li J, Yang S, Huang K, Dong X, Sui C
and Zhang H: P57 and cyclin G1 express differentially in
proliferative phase endometrium and early pregnancy decidua. Int J
Clin Exp Med. 8:5144–5149. 2015.PubMed/NCBI
|
32
|
Korgun ET, Celik-Ozenci C, Acar N, Cayli
S, Desoye G and Demir R: Location of cell cycle regulators cyclin
B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57
in human first trimester placenta and deciduas. Histochem Cell
Biol. 125:615–624. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Matsuoka S, Edwards MC, Bai C, Parker S,
Zhang P, Baldini A, Harper JW and Elledge SJ: p57KIP2, a
structurally distinct member of the p21CIP1 Cdk inhibitor family,
is a candidate tumor suppressor gene. Genes Dev. 9:650–662. 1995.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Minden A and Karin M: Regulation and
function of the JNK subgroup of MAP kinases. Biochim Biophys Acta.
1333:F85–F104. 1997.PubMed/NCBI
|